OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTI

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 20 units of OXYMETAZOLINE HYDROCHLORIDE NASAL SOLUTION with NSN 6505016806726, at a unit price of $1.39, resulting in a total contract value of $27.80. The award was issued on July 14, 2026, with delivery required by July 29, 2026, to Fort Bragg, North Carolina, under FOB destination terms, meaning the contractor assumes all transportation costs and risks until final delivery. Inspection and acceptance occur at the destination, and payment is governed by code SL4701 via the Defense Finance and Accounting Service in Columbus, Ohio, with net 30-day terms applicable due to the contractor’s certification as a Small Disadvantaged Business and Women-Owned Small Business. The contract references traceable shipping methods and prohibits parcel post, indicating a requirement for secure, trackable logistics, though no specific packaging standards such as MIL-STD are cited. The offering firm has affirmed its small business status and socio-economic certifications, triggering compliance obligations under FAR Part 19 and SAM.gov reporting, yet no formal evaluation factors, special requirements, or detailed specifications beyond the NSN and quantity are included in this delivery order, suggesting reliance on the underlying indefinite delivery/indefinite quantity agreement for broader terms. No contract clauses, attachments, or Section M evaluation criteria are present in the documentation, consistent with its nature as a low-value, one-time procurement under an existing master contract.